| Course | HLTH 8475 Advanced Program Implementation and Evaluation |
|---|---|
| Week | Week 1 |
| Paper type | Framing post |
| Length | About 530 words, 3 pages |
| Format | Discussion post, APA 7 citations |
| School | Walden University |
| Program | PhD in Public Health |
| Updated | October 2026 |
Free sample paper for HLTH 8475 Week 1
Week 1 Discussion: Why Programs Change Between Approval and Delivery
Eleven Clearances Before the First Prescription: Counting What a Rural Pharmacy PrEP Program Needs Approved Before Anyone Starts HIV Prevention, and What the Count Means for How It Should Be Evaluated
Pressman and Wildavsky (1973) followed a federal jobs program in Oakland and showed how a plan approved in Washington lost its shape as it passed through agency after agency, each of which had to agree before anything happened. Their point was arithmetic: even if each clearance is likely, a long chain of them makes the whole outcome unlikely, and each one is a place where the program can be delayed or quietly changed.
I want to apply that arithmetic to a program I will follow all term: a rural health district, a composite, that plans to offer HIV pre-exposure prophylaxis, PrEP, through four independent community pharmacies. Pharmacists would assess clients, order HIV and other tests, start PrEP and manage follow-up under a collaborative practice agreement with the district's medical director, because our state does not give pharmacists independent prescribing authority for PrEP. Most states do not; a recent review found that only 17 of 50 states had statewide authority for pharmacists to provide PrEP at community pharmacies, and that in the others most pharmacists work through collaborative agreements (Wang et al., 2024).
Here is my count of clearances before the first prescription: the district board's approval; the medical director's signature on the collaborative practice agreement; the state board of pharmacy's acceptance of the protocol; each of four pharmacy owners' agreement; training for at least two pharmacists per site; a contract with a laboratory for HIV, kidney function and sexually transmitted infection tests; an electronic route for lab results to reach pharmacists; credentialing with the two main commercial insurers and the state Medicaid program so pharmacists' services can be billed; a patient assistance pathway for the uninsured; a referral agreement with the district's disease intervention specialists; and a privacy plan for counseling in small pharmacies. That is eleven. If each had a 90% chance of going smoothly, the chance that all eleven would is about 31%.
The consequence for evaluation is the point of this post. When the program is finally delivered, it will almost certainly differ from the plan. Some pharmacies may not bill insurers; one may not have a private room; lab results may arrive late at another. An evaluation that measures only clinical outcomes, such as how many people stay on PrEP, would not know whether a poor result came from the program or from a broken link. The evaluation has to measure implementation first: which clearances held, at which sites, and what was actually delivered. The billing link deserves particular attention, because a successful pharmacist-managed PrEP clinic in Seattle reported that its financial sustainability depended on pharmacists being able to bill insurers under state law (Tung et al., 2018).
Question for the board: how many clearances stand between your program and its first client?
Reply to Ines
Ines, you counted six clearances for your school vaccination program and called it simple. I wonder whether any of your six depend on each other, like a consent form that cannot be finalized until the school board approves it. Sequential clearances compound delay.
References
Pressman, J. L., & Wildavsky, A. (1973). Implementation: How great expectations in Washington are dashed in Oakland. University of California Press.
Tung, E. L., Thomas, A., Eichner, A., & Shalit, P. (2018). Implementation of a community pharmacy-based pre-exposure prophylaxis service: A novel model for pre-exposure prophylaxis care. Sexual Health, 15(6), 556-561. https://doi.org/10.1071/SH18084
Wang, H., Guinn, D., Ramisetty, X. R., Giordano, T. P., & Poon, I. O. (2024). A review of studies on HIV pre-exposure prophylaxis in community pharmacies in states with restrictive pharmacist prescription authority in the United States. Pharmacy, 12(5), Article 144. https://doi.org/10.3390/pharmacy12050144
Reading the HLTH 8475 Week 1 instructions
The opening thread asks students to introduce the program they will follow all term and to frame the gap between a program as approved and as delivered. Faculty expect the post to use a concept from the readings, often Pressman and Wildavsky's account of complex joint action, and to apply it concretely to the chosen program. A count of the approvals, partners or steps a program needs is a strong way to do this. The post should end with a consequence for evaluation, not only a prediction of trouble. Sources should support both the framing and any claims about the program's context, and a reply should apply the same reasoning to a classmate's program.
How this HLTH 8475 Week 1 example is built
The opening summarizes Pressman and Wildavsky's Oakland study and its arithmetic of clearances. The second paragraph introduces the composite rural pharmacy PrEP program and cites Wang and colleagues on how few states allow independent pharmacist prescribing. The third lists eleven clearances and calculates the chance that all hold if each is 90% likely. The fourth draws the evaluation consequence: measure implementation before outcomes, because a poor result may reflect a broken link rather than a weak program, and it cites Tung and colleagues on how a pioneering pharmacy PrEP clinic depended on billing. The board question asks for classmates' own counts. The reply to Ines notes that dependent clearances compound delay.
Where the marks sit in the HLTH 8475 Week 1 rubric
Faculty grade this post on whether the framing concept does real work. A post that summarizes Pressman and Wildavsky without applying their idea earns middle marks. Credit grows when the post makes the concept concrete for one program, such as by counting clearances, and when it draws a specific consequence for how the program should be evaluated. Accurate use of sources about the program's context, such as legal authority for pharmacists, adds weight. The rubric also rewards restraint: the post predicts that delivery will differ from the plan, not that the program will fail. Replies earn credit for extending the reasoning to a classmate's program, for example by noticing dependent steps. A board question that invites classmates to apply the same count keeps the thread useful.
Common HLTH 8475 Week 1 mistakes, and how to avoid them
Opening posts in implementation courses often describe the program's goals and the population it will serve, with little attention to how it will actually get into place. Others predict failure without saying why. To write a stronger post, list everything that must be agreed, signed, contracted or built before your program serves its first person. Count it. Ask what happens if one link fails. Say what that means for how you will evaluate the program, especially which implementation measures you will need. Keep the introduction short and the reasoning concrete. We can also draft a framing post around the clearances in your own program.
Get a HLTH 8475 Week 1 example written to your instructions
Send the Week 1 prompt and rubric exactly as your section shows them, plus the program you expect to follow all term if one is chosen. The framing post comes back within 24-48h and the first request is free. Where no program has been picked yet, an invented one stands in and says so.
More HLTH 8475 papers and PhD in Public Health samples
- HLTH 8475 Week 2: Program Adaptation Post
- HLTH 8475 Week 3: Implementation Logic Model
- HLTH 8475 Week 4: Staged Implementation Plan
- HLTH 8475 Week 5: Pre-Set Measurement Plan
- HLTH 8475 Week 6: Reach Measure Peer Critique
- HLTH 8475 Week 7: Six-Month Process Evaluation
- HLTH 8475 Week 8: Rival Explanations Post
- HLTH 8475 Week 9: Site-Level Outcome Analysis
- HLTH 8475 Week 10: Program Failure Counterargument
- HLTH 8475 Week 11: Utilization-Focused Evaluation Report
- HLTH 8402 Week 1: Leading Across Difference Post
- HLTH 8392 Week 1: Leadership Language Post
- HLTH 8317 Week 1: Budget by Origin Framing Post
- HLTH 8247 Week 1: Person and Situation Post
HLTH 8475 Week 1 questions, answered
Does the post need to cite Pressman and Wildavsky?
No particular source is required unless your prompt names one. The sample uses their book because its central idea, that agreement across many parties compounds into improbability, suits a framing week. Proctor and colleagues' implementation outcomes or the CFIR domains could carry the same claim, and your rubric may prefer the course text. What earns credit is applying the idea, not the name.
Is the post allowed to predict that the program will fail?
It predicts nothing about outcomes. What it argues is narrower: the delivered program will differ from the written one in ways nobody can fully forecast, so the evaluation has to watch delivery from the start. A framing post forecasting failure has skipped over the evidence the coming weeks exist to gather.
Where can I find a free HLTH 8475 Week 1 sample paper?
The complete Week 1 framing post for HLTH 8475 appears above, counting eleven clearances for a rural pharmacy PrEP program and drawing an evaluation consequence, with a reply and three references.
Why use a pharmacy PrEP program as the term's example?
Because it depends on many separate parties, a medical director, four pharmacy owners, a laboratory, insurers and referral partners, which makes the gap between the approved and delivered program easy to see and important to measure.
What is the evaluation consequence of the clearance count?
That the program will almost certainly be delivered differently from its plan, so the evaluation must measure implementation, which clearances held at which sites, before interpreting any clinical outcome.